Literature DB >> 11810011

Significance of early CT signs in acute stroke. A CT scan-diffusion MRI study.

Assia Jaillard1, Marc Hommel, Alison E Baird, Italo Linfante, Rafael H Llinas, Louis R Caplan, Robert R Edelman, Steven Warach.   

Abstract

OBJECTIVE: To study the pathophysiology of early CT signs.
BACKGROUND: Early CT signs, due to an increase in tissue water content, are commonly attributed to cytotoxic edema and development of irreversible injury. This may have important implications for thrombolysis.
METHODS: In patients with acute ischemic stroke in the middle cerebral artery territory, the areas of early CT signs and diffusion weighted imaging (DWI) hypersignal were independently assessed and drawn on a standardized atlas. Then, patients were classified into three groups (early CT signs larger than, similar to or smaller than DWI hypersignal) and compared with perfusion weighted imaging (PWI).
RESULTS: Of 16 patients, CT scanning was performed with a median time of 3 h after onset and early CT scan signs were recorded in 10/16 patients (62.5%). DWI signal hyperintensity was present in 15/16 (94%) patients. In 7/16 (43%) patients, the area with early CT scan signs was larger than the DWI lesion ('CT-larger group'). Only in 2/16 (12%) patients were the areas matching ('matching group'). In 7/16 (43%) the DWI lesion was larger than the early CT scan signs area ('DWI-larger group'). When compared with PWI, the areas of early CT signs were larger than DWI hypersignal and were matching with PWI abnormalities (rMTT) in 2 cases, suggesting that they may represent a reversible process.
CONCLUSIONS: Early CT signs might have a potential dual fate: infarction or reversibility. Other techniques of recognizing reversible ischemic damage, such as DWI-PWI, are needed to improve acute stroke diagnosis and management. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 11810011     DOI: 10.1159/000047746

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  7 in total

1.  Reversibility of extensive hemispheric cytotoxic cerebral edema following subarachnoid hemorrhage.

Authors:  Nancy McLaughlin; Michel W Bojanowski
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

2.  Reversed discrepancy between CT and diffusion-weighted MR imaging in acute ischemic stroke.

Authors:  E Y Kim; J W Ryoo; H G Roh; K H Lee; S S Kim; I C Song; K-H Chang; D G Na
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

3.  Recent Administration of Iodinated Contrast Renders Core Infarct Estimation Inaccurate Using RAPID Software.

Authors:  A Z Copelan; E R Smith; G T Drocton; K H Narsinh; D Murph; R S Khangura; Z J Hartley; A A Abla; W P Dillon; C F Dowd; R T Higashida; V V Halbach; S W Hetts; D L Cooke; K Keenan; J Nelson; D Mccoy; M Ciano; M R Amans
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-19       Impact factor: 3.825

4.  CT perfusion parameter values in regions of diffusion abnormalities.

Authors:  Marcello Galvez; Gerald E York; James D Eastwood
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

5.  Association of early CT abnormalities, infarct size, and apparent diffusion coefficient reduction in acute ischemic stroke.

Authors:  Diederik M Somford; Michael P Marks; Vincent N Thijs; David C Tong
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

6.  Peripheral markers of brain damage and blood-brain barrier dysfunction.

Authors:  Nicola Marchi; Peter Rasmussen; Miranda Kapural; Vince Fazio; Kelly Kight; Marc R Mayberg; Andrew Kanner; Barbara Ayumar; Ben Albensi; Marco Cavaglia; Damir Janigro
Journal:  Restor Neurol Neurosci       Date:  2003       Impact factor: 2.406

7.  Early ischemic CT changes before thrombolysis: The influence of age and diabetes mellitus.

Authors:  Lars Thomassen; Ulrike Waje-Andreassen; Halvor Naess
Journal:  Ther Clin Risk Manag       Date:  2008-08       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.